-
-
-
-
-
-
-
FDA rejects Vanda's HETLIOZ application for jet lag disorder
-
-
-
-
-
-
-
argenx discontinues thyroid eye disease studies after futility analysis
-
-
-
-
-
-
-
enVVeno receives unfavorable FDA appeal decision for VenoValve device
-
-
-
-
-
-
-
Sarepta completes confirmatory study for duchenne therapies, study misses primary endpoint
-
-
-
-
-
-
-
CDC Panel Votes To End Universal Recommendation For Covid Shots - Bloomberg
-
-
-
-
-
-
-
Zai Lab pauses regulatory filing for bemarituzumab after trial results
-
-
-
-
-
-
-
FDA rejects PTC Therapeutics' vatiquinone for Friedreich's ataxia
-
5,908 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Hot FDA News reports.

